Previous studies have reported excessive expression of apoptosis‐antagonizing transcription factor (
AATF
) in various tumors, where it reinforces the generation and development of cancers and is linked to the clinical outcome. Nevertheless, the expression and influence of
AATF
in Wilms’ tumor (
WT
) is largely unknown. Here, we discovered that
AATF
expression was markedly increased in
WT
tissues as compared to the surrounding normal tissues. Elevated levels of
AATF
expression were related to tumor relapse and pulmonary metastasis, congruent with it being a predictor of clinical outcome in people suffering from
WT
. Proliferation, invasion, and migration of
WT
cells were suppressed by knockdown of
AATF
and promoted by
AATF
overexpression
in vitro
. Furthermore, the tumor generation capability of
WT
cells noticeably decreased after knockout of
AATF
in vivo
. The phosphoinositide‐3‐kinase (
PI
3K)/
AKT
pathway modulated the activity of
AATF
in
WT
. The findings of our study indicate that
AATF
expression is increased in
WT
and can serve as a predictor of clinical outcome; in addition, it may enhance the development of
WT
via the
PI
3K/
AKT
axis and may be a promising marker for
WT
diagnosis and therapy.